180 related articles for article (PubMed ID: 25871520)
41. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.
Yuan P; Thompson TB; Wurzburg BA; Paterson RG; Lamb RA; Jardetzky TS
Structure; 2005 May; 13(5):803-15. PubMed ID: 15893670
[TBL] [Abstract][Full Text] [Related]
42. Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery.
El-Deeb IM; Guillon P; Winger M; Eveno T; Haselhorst T; Dyason JC; von Itzstein M
J Med Chem; 2014 Sep; 57(18):7613-23. PubMed ID: 25198831
[TBL] [Abstract][Full Text] [Related]
43. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
[TBL] [Abstract][Full Text] [Related]
44. Analysis of parainfluenza virus-5 hemagglutinin-neuraminidase protein mutants that are blocked in internalization and degradation.
Robach JG; Lamb RA
Virology; 2010 Oct; 406(2):189-201. PubMed ID: 20684967
[TBL] [Abstract][Full Text] [Related]
45. Receptor binding specificity of recent human H3N2 influenza viruses.
Kumari K; Gulati S; Smith DF; Gulati U; Cummings RD; Air GM
Virol J; 2007 May; 4():42. PubMed ID: 17490484
[TBL] [Abstract][Full Text] [Related]
46. Exposing the flexibility of human parainfluenza virus hemagglutinin-neuraminidase.
Winger M; von Itzstein M
J Am Chem Soc; 2012 Nov; 134(44):18447-52. PubMed ID: 23057491
[TBL] [Abstract][Full Text] [Related]
47. Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein.
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang Z
Virus Res; 2013 Jun; 174(1-2):137-47. PubMed ID: 23562646
[TBL] [Abstract][Full Text] [Related]
48. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity.
Iorio RM; Field GM; Sauvron JM; Mirza AM; Deng R; Mahon PJ; Langedijk JP
J Virol; 2001 Feb; 75(4):1918-27. PubMed ID: 11160691
[TBL] [Abstract][Full Text] [Related]
49. Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3.
Jung C; Grzybowski BN; Tong S; Cheng L; Compans RW; Le Doux JM
Biotechnol Prog; 2004; 20(6):1810-6. PubMed ID: 15575716
[TBL] [Abstract][Full Text] [Related]
50. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle.
Huberman K; Peluso RW; Moscona A
Virology; 1995 Dec; 214(1):294-300. PubMed ID: 8525632
[TBL] [Abstract][Full Text] [Related]
51. Virus-receptor interactions of human parainfluenza viruses types 1, 2 and 3.
Ah-Tye C; Schwartz S; Huberman K; Carlin E; Moscona A
Microb Pathog; 1999 Nov; 27(5):329-36. PubMed ID: 10545258
[TBL] [Abstract][Full Text] [Related]
52. Roles of conserved residues in the receptor binding sites of human parainfluenza virus type 3 HN protein.
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren G; Sun CX; Li ZM; Wang Z
Microb Pathog; 2021 Sep; 158():105053. PubMed ID: 34147587
[TBL] [Abstract][Full Text] [Related]
53. A I131V Substitution in the Fusion Glycoprotein of Human Parainfluenza Virus Type 1 Enhances Syncytium Formation and Virus Growth.
Fukushima K; Takahashi T; Takaguchi M; Ito S; Suzuki C; Agarikuchi T; Kurebayashi Y; Minami A; Suzuki T
Biol Pharm Bull; 2019; 42(5):827-832. PubMed ID: 31061326
[TBL] [Abstract][Full Text] [Related]
54. Phylogenetic analysis of human parainfluenza type 3 virus strains responsible for the outbreak during the COVID-19 pandemic in Seoul, South Korea.
Kim HN; Yoon SY; Lim CS; Lee CK; Yoon J
J Clin Virol; 2022 Aug; 153():105213. PubMed ID: 35724578
[TBL] [Abstract][Full Text] [Related]
55. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.
Crennell S; Takimoto T; Portner A; Taylor G
Nat Struct Biol; 2000 Nov; 7(11):1068-74. PubMed ID: 11062565
[TBL] [Abstract][Full Text] [Related]
56. Function and immunogenicity of human parainfluenza virus 3 glycoproteins expressed by recombinant adenoviruses.
Ebata SN; Prevec L; Graham FL; Dimock K
Virus Res; 1992 Jun; 24(1):21-33. PubMed ID: 1320799
[TBL] [Abstract][Full Text] [Related]
57. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR
J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318
[TBL] [Abstract][Full Text] [Related]
58. Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to alpha2,8-linked sialic acid.
Wu W; Air GM
Virology; 2004 Aug; 325(2):340-50. PubMed ID: 15246273
[TBL] [Abstract][Full Text] [Related]
59. A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death.
Takaguchi M; Takahashi T; Hosokawa C; Ueyama H; Fukushima K; Hayakawa T; Itoh K; Ikeda K; Suzuki T
J Biochem; 2011 Feb; 149(2):191-202. PubMed ID: 21186250
[TBL] [Abstract][Full Text] [Related]
60. The Fusion Protein Specificity of the Parainfluenza Virus Hemagglutinin-Neuraminidase Protein Is Not Solely Defined by the Primary Structure of Its Stalk Domain.
Tsurudome M; Ito M; Ohtsuka J; Hara K; Komada H; Nishio M; Nosaka T
J Virol; 2015 Dec; 89(24):12374-87. PubMed ID: 26423949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
